Published in J Hosp Infect on December 01, 1998
Hantavirus pulmonary syndrome, United States, 1993-2009. Emerg Infect Dis (2011) 1.48
Human pathogenic hantaviruses and prevention of infection. Hum Vaccin (2011) 1.40
Treatment of hantavirus pulmonary syndrome. Antiviral Res (2007) 1.21
Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011. Emerg Infect Dis (2014) 0.97
Effects of mefloquine use on Plasmodium vivax multidrug resistance. Emerg Infect Dis (2014) 0.86
Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Res (2008) 0.86
Small interfering RNA inhibition of Andes virus replication. PLoS One (2014) 0.78
Plasmid cloning vehicles derived from plasmids ColE1, F, R6K, and RK2. Methods Enzymol (1979) 13.61
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science (1999) 6.94
Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Regions of broad-host-range plasmid RK2 which are essential for replication and maintenance. J Bacteriol (1980) 5.45
Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol (1995) 5.30
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14
Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis (1994) 4.97
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
Generation in vitro of deletions in the broad host range plasmid RK2 using phage Mu insertions and a restriction endonuclease. Gene (1976) 4.35
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
Physical and genetic studies with restriction endonucleases on the broad host-range plasmid RK2. Mol Gen Genet (1977) 4.28
Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science (1971) 4.27
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
Diagnosis of iron-deficiency anemia in the elderly. Am J Med (1990) 3.77
Accumulation of chlorpyrifos on residential surfaces and toys accessible to children. Environ Health Perspect (1998) 3.75
Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg (1981) 3.72
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62
Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55
Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47
Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis (2001) 3.42
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34
Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24
Reye's syndrome in the United States from 1981 through 1997. N Engl J Med (1999) 3.20
Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science (1971) 3.14
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
Molecular vehicle properties of the broad host range plasmid RK2. Science (1975) 2.97
Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97
Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein. Proc Natl Acad Sci U S A (1977) 2.93
Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Excessive infant crying: a controlled study of mothers helping mothers. Pediatrics (1994) 2.72
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69
Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 2.61
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57
Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc Natl Acad Sci U S A (1992) 2.56
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44
A sensitive and specific method for the determination of histomine in human whole blood and plasma. Hoppe Seylers Z Physiol Chem (1972) 2.43
Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res (1999) 2.38
Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis (2007) 2.37
Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36
Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36
The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect (2001) 2.30
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A (1981) 2.26
Feline leukemia virus: biochemical and immunological characterization of gag gene-coded structural proteins. J Virol (1977) 2.26
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22